Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ELOX Stock Forecast, Price Targets, Chart, Dividends & Analysis

Eloxx Pharmaceuticals Inc. logo

Eloxx Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

0.00
 
USD
  
0.00
  
(9900.00%)
Previous close: 1e-06  Open: 0.0001  Bid:   Ask:
52 week range    
0.00   
   4.49
Mkt Cap: 2 M  Avg Vol (90 Days): 2,521
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Monday 7th October 2024

Stock Rankings

38
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Returns

Peers

StockDividendMarket Cap (B)PEPrice ($)

NWBO

NYMX

0.2

OHCS

OMIC

0 B013.48
Financials

ELOX Income Statement

Annual
Jun-14Jun-15Jun-16Jun-17Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends5 M838925.0179154.0397904.0
Amortization of intangibles-331381.0
Basic EPS from continuing operations-1.34-0.86-38.15-16.65
Basic EPS total-1.34-0.86-38.15-16.65
Basic weighted shares outstanding136917.0360425.0508067.023 M124409.0810912.038 M40 M2 M2 M
Cost of sales2 M2 M1 M
Depreciation-18275.0-152097.0-93394.0-44075.0-39000.0-216000.087000.068000.0114000.077000.0
DepreciationAndAmortization-18275.0-152097.0-93394.0-44075.0-39000.0-216000.087000.068000.0114000.077000.0
Diluted EPS total-101.2-52.4-16.8-0.27190.0-58.0-1.34-0.86-38.15-16.65
Diluted normalized net income/share-38.15-16.65
Diluted weighted shares outstanding91158.0344728.0507259.021 M111652.0813534.038 M40 M2 M2 M
Earnings from equity interest-14500.0
EarningsFromEquityInterestNetOfTax-14500.0
GainOnSaleOfPPE149728.0
GainOnSaleOfSecurity3313.02 M249025.0301000.0-15000.0
GeneralAndAdministrativeExpense4 M3 M2 M1 M3 M26 M24 M15 M20 M11 M
Gross operating profit-2 M-2 M329027.0-1 M
ImpairmentOfCapitalAssets330190.08 M6 M
Income before tax-9 M-18 M-9 M-7 M-21 M-47 M-51 M-27 M-67 M-36 M
Income restructuring and M&A11 M2 M-1 M
Income taxes-680000.0-1 M-10 M122000.0
Interest income-77438.09638.0-533.0-265203.0601000.01 M337000.08000.0274000.0
InterestExpenseNonOperating-85629.0-43000.0-7000.02 M1 M1 M2 M
InterestIncomeOperating-1 M
MiscOtherSpecialCharges-285356.0-824000.0502000.0-319000.0-1 M-709000.0-2 M
Net income from total operations-9 M-18 M-8 M-6 M-24 M-47 M-51 M-35 M-67 M-36 M
NetIncomeCommonStockholders-14 M-19 M-8 M-6 M-24 M-47 M-51 M-27 M-67 M-36 M
NetIncomeContinuousOperations-9 M-18 M-8 M-6 M-24 M-47 M-51 M-35 M-67 M-36 M
NetNonOperatingInterestIncomeExpense-77438.09638.0-533.0386281.0-2 M608000.0-544000.0-1 M-1 M-2 M
NonRecurringOperationExpense-624531.0
Normalized income-54 M-28 M
Operating income-9 M-10 M-3 M-4 M-20 M-48 M-51 M-33 M-66 M-34 M
Operating income before depreciation (EBITDA)-9 M-18 M-9 M-7 M-21 M-47 M-48 M-33 M-65 M-33 M
OperatingExpense7 M8 M4 M2 M-20 M-48 M51 M33 M66 M34 M
Other income net544978.0-3313.0-293560.02 M824000.0-502000.0319000.01 M709000.02 M
OtherGandA4 M3 M2 M1 M3 M26 M24 M15 M20 M11 M
OtherImpairmentOfCapitalAssets2 M3 M
OtherOperatingExpenses1 M594000.0500000.0-4 M1 M700000.0
OtherunderPreferredStockDividend5 M838925.0179154.0397904.0
PreferredStockDividends5 M838925.0179154.0397904.0
RentAndLandingFees4 M3 M2 M1 M3 M26 M
Research & development expense3 M5 M2 M733661.016 M20 M26 M15 M46 M24 M
ResearchExpense3 M5 M2 M733661.016 M20 M26 M15 M46 M24 M
RestructringAndMnAIncome11 M2 M-1 M
Revenue per share-331381.0
SalariesAndWages-1 M-1 M-485682.0-436363.0-101000.0-13 M
Selling Gen & administrative expense4 M3 M2 M1 M3 M26 M24 M15 M20 M11 M
Special income/charges-11 M-8 M-6 M-2 M1 M
Total Income available for interest expense (EBIT)-9 M-18 M-9 M-7 M-21 M-47 M-49 M-33 M-65 M-34 M
Total common shares outstanding17307.025487.025620.051 M688193.0896502.01 M1 M2 M2 M
Total net income-9 M-18 M-8 M-6 M-24 M-47 M-51 M-35 M-67 M-36 M
Total ordinary shares3 M3 M3 M3 M3 M3 M3 M3 M3 M3 M
Total revenues100000.075000.0329027.0
TotalExpenses9 M10 M4 M4 M-20 M-48 M51 M33 M66 M34 M
TotalRevenue100000.075000.0329027.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University